# Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome

> **NCT05255328** · NA · UNKNOWN · sponsor: **Hospital Universitario 12 de Octubre** · enrollment: 9 (actual)

## Conditions studied

- MELAS Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Glutamine oral supplement

## Key facts

- **NCT ID:** NCT05255328
- **Lead sponsor:** Hospital Universitario 12 de Octubre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-07-15
- **Final completion:** 2024-07-24
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05255328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05255328, "Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05255328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*